KLS-2031 is under clinical development by Kolon Life Science and currently in Phase II for Radiculopathy. According to GlobalData, Phase II drugs for Radiculopathy does not have sufficient historical ...

These analyses suggest that trial design innovation may better control the placebo response and separate the treatment effect of suzetrigine from placebo in future studies, which Vertex will ...

– Treatment with the highly selective NaV1.8 pain signal inhibitor suzetrigine met the primary endpoint with a statistically significant and clinically meaningful 2.02 point within-group ...

"About 40% of women in our high-risk group had been diagnosed with the severe cervical precancer or cancer that requires treatment,” said lead researcher Jiayao Lei, an assistant professor of medical ...

Getting checked for cervical cancer is looking to become a lot more convenient. An influential panel of experts is calling for new changes to the current recommendations surrounding cervical ...

Share on Pinterest New cervical cancer screening guidelines ... including a lack of access to insurance and appropriate treatment. We often see that many women believe they will experience ...

That means the XEC strain is more transmissible than many of its predecessors, but on the upside, the symptoms associated with it will likely be milder, Roberts said. Many of these symptoms also ...

Women ages 30 and older can now use a swab to collect their own vaginal samples to screen for cervical cancer, according to new guidelines from a national health task force. Draft recommendations ...

Eight women whose smear tests were misread by screeners went on to develop cancer, a major review into cervical screening ... were reviewed and had to receive treatment. All these women had ...

Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30 ...